- call +1-201-465-4211
- email sales@mrinsights.biz
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
Scope of the Report:
This report studies the Biopharmaceutical market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biopharmaceutical market by product type and applications/end industries.
North America has the highest market share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet market opportunities in the region.
The global Biopharmaceutical market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biopharmaceutical.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Other
Market Segment by Applications, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biopharmaceutical Market Overview
1.1 Product Overview and Scope of Biopharmaceutical
1.2 Classification of Biopharmaceutical by Types
1.2.1 Global Biopharmaceutical Revenue Comparison by Types (2017-2023)
1.2.2 Global Biopharmaceutical Revenue Market Share by Types in 2017
1.2.3 Monoclonal Antibodies
1.2.4 Interferon
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Other
1.3 Global Biopharmaceutical Market by Application
1.3.1 Global Biopharmaceutical Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Global Biopharmaceutical Market by Regions
1.4.1 Global Biopharmaceutical Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biopharmaceutical Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biopharmaceutical Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical Status and Prospect (2013-2023)
1.5 Global Market Size of Biopharmaceutical (2013-2023)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Biopharmaceutical Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Biopharmaceutical Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
2.3 AbbVie
2.3.1 Business Overview
2.3.2 Biopharmaceutical Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi-Aventis
2.4.1 Business Overview
2.4.2 Biopharmaceutical Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi-Aventis Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Biopharmaceutical Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Biopharmaceutical Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novo Nordisk
2.7.1 Business Overview
2.7.2 Biopharmaceutical Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novo Nordisk Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eli Lilly
2.8.1 Business Overview
2.8.2 Biopharmaceutical Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis
2.9.1 Business Overview
2.9.2 Biopharmaceutical Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck
2.10.1 Business Overview
2.10.2 Biopharmaceutical Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Biopharmaceutical Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biopharmaceutical Market Competition, by Players
3.1 Global Biopharmaceutical Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biopharmaceutical Players Market Share
3.2.2 Top 10 Biopharmaceutical Players Market Share
3.3 Market Competition Trend
4 Global Biopharmaceutical Market Size by Regions
4.1 Global Biopharmaceutical Revenue and Market Share by Regions
4.2 North America Biopharmaceutical Revenue and Growth Rate (2013-2018)
4.3 Europe Biopharmaceutical Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biopharmaceutical Revenue and Growth Rate (2013-2018)
4.5 South America Biopharmaceutical Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biopharmaceutical Revenue and Growth Rate (2013-2018)
5 North America Biopharmaceutical Revenue by Countries
5.1 North America Biopharmaceutical Revenue by Countries (2013-2018)
5.2 USA Biopharmaceutical Revenue and Growth Rate (2013-2018)
5.3 Canada Biopharmaceutical Revenue and Growth Rate (2013-2018)
5.4 Mexico Biopharmaceutical Revenue and Growth Rate (2013-2018)
6 Europe Biopharmaceutical Revenue by Countries
6.1 Europe Biopharmaceutical Revenue by Countries (2013-2018)
6.2 Germany Biopharmaceutical Revenue and Growth Rate (2013-2018)
6.3 UK Biopharmaceutical Revenue and Growth Rate (2013-2018)
6.4 France Biopharmaceutical Revenue and Growth Rate (2013-2018)
6.5 Russia Biopharmaceutical Revenue and Growth Rate (2013-2018)
6.6 Italy Biopharmaceutical Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biopharmaceutical Revenue by Countries
7.1 Asia-Pacific Biopharmaceutical Revenue by Countries (2013-2018)
7.2 China Biopharmaceutical Revenue and Growth Rate (2013-2018)
7.3 Japan Biopharmaceutical Revenue and Growth Rate (2013-2018)
7.4 Korea Biopharmaceutical Revenue and Growth Rate (2013-2018)
7.5 India Biopharmaceutical Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biopharmaceutical Revenue and Growth Rate (2013-2018)
8 South America Biopharmaceutical Revenue by Countries
8.1 South America Biopharmaceutical Revenue by Countries (2013-2018)
8.2 Brazil Biopharmaceutical Revenue and Growth Rate (2013-2018)
8.3 Argentina Biopharmaceutical Revenue and Growth Rate (2013-2018)
8.4 Colombia Biopharmaceutical Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biopharmaceutical by Countries
9.1 Middle East and Africa Biopharmaceutical Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biopharmaceutical Revenue and Growth Rate (2013-2018)
9.3 UAE Biopharmaceutical Revenue and Growth Rate (2013-2018)
9.4 Egypt Biopharmaceutical Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biopharmaceutical Revenue and Growth Rate (2013-2018)
9.6 South Africa Biopharmaceutical Revenue and Growth Rate (2013-2018)
10 Global Biopharmaceutical Market Segment by Type
10.1 Global Biopharmaceutical Revenue and Market Share by Type (2013-2018)
10.2 Global Biopharmaceutical Market Forecast by Type (2018-2023)
10.3 Monoclonal Antibodies Revenue Growth Rate (2013-2023)
10.4 Interferon Revenue Growth Rate (2013-2023)
10.5 Erythropoietin Revenue Growth Rate (2013-2023)
10.6 Insulin Revenue Growth Rate (2013-2023)
10.7 Other Revenue Growth Rate (2013-2023)
11 Global Biopharmaceutical Market Segment by Application
11.1 Global Biopharmaceutical Revenue Market Share by Application (2013-2018)
11.2 Biopharmaceutical Market Forecast by Application (2018-2023)
11.3 Tumor Revenue Growth (2013-2018)
11.4 Diabetes Revenue Growth (2013-2018)
11.5 Cardiovascular Revenue Growth (2013-2018)
11.6 Hemophilia Revenue Growth (2013-2018)
11.7 Other Revenue Growth (2013-2018)
12 Global Biopharmaceutical Market Size Forecast (2018-2023)
12.1 Global Biopharmaceutical Market Size Forecast (2018-2023)
12.2 Global Biopharmaceutical Market Forecast by Regions (2018-2023)
12.3 North America Biopharmaceutical Revenue Market Forecast (2018-2023)
12.4 Europe Biopharmaceutical Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biopharmaceutical Revenue Market Forecast (2018-2023)
12.6 South America Biopharmaceutical Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biopharmaceutical Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biopharmaceutical Picture
Table Product Specifications of Biopharmaceutical
Table Global Biopharmaceutical and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
